Avanos Medical Inc (AVNS) Growth Rates Comparisons to Medical Equipment & Supplies Industry, Sector, Market. Sales, Income, EPS
CSIMarket
 
Avanos Medical Inc   (NYSE: AVNS)
 

Avanos Medical Inc Growth Comparisons

Select each growth Category to receive further Information





AVNS Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) 9.23 % 7.83 % 9.19 % 10.9 %
Q / Q Revenue Growth (Q1 MRQ) 0.72 % -1.87 % -3.28 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) 3.82 % 7.21 % 7.98 % %
Sequential Revenue Growth (for 12 months ending Q1 TTM) 2.2 % 1.5 % 2.03 % 2.61 %
Revenue 5 Year Average Growth - 10.68 % 8.65 % 10.59 %


AVNS's Growth Comparisons in I. Quarter 2026




Comparing 9.23% year on year Revenue growth in the first quarter 2026, Avanos Medical Inc outperformed the 7.83% growth in the Medical Equipment & Supplies industry, and 9.19% growth in the Healthcare sector.

Comparing the company's Revenue to the fourth quarter results, sales were higher by 0.72% . On the yearly basis, average annual sales growth for Avanos Medical Inc is %, while S & P 500's including only Businesses with the first quarter 2026 earnings, average annual sales growth is 10.59% over the past five years.

AVNS Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
SNS
22.65 %
-
PM R
0.18 %
-
Corporate and other
-81.37 %
-
Total Specialty Nutrition Systems
22.65 %
-
Enteral feeding
13.56 %
-
Neonate solutions
48.12 %
-
Surgical pain and recovery
-11.02 %
-
Radiofrequency ablation
8.83 %
-
Total
9.23 %
-


Growth Rates of AVNS's Income in the first quarter 2026


AVNS Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) -13.59 % 14.39 % 5.13 % 97.6 %
Sequential Operating Income Change (Q1 MRQ) -82.98 % 96.14 % 0.89 % 48.13 %
Y / Y Operating Income Growth (Q1 TTM) - 13.68 % 30.7 % 40.67 %
Sequential Operating Income Growth (Q1 TTM) - 2.92 % 4.82 % 20.86 %
Operating Income 5 Year Avg. Change - 11.5 % 10.39 % 18.76 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) -22.73 % -9.84 % -25.81 % 90.69 %
Sequential Income from Cont. Ops. Change (Q1 MRQ) - 19.69 % -66.16 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) - 16.79 % 2.68 % 57.33 %
Sequential Income from Cont. Ops. Change (Q1 TTM) - -2.7 % -5.02 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change - 5.35 % 0.17 % -28.52 %

AVNS Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) -22.73 % -12.27 % -26.29 % 90.69 %
Q / Q Net Income Growth (Q1 MRQ) - 44.98 % -0.86 % 27.07 %
Y / Y Net Income Change (Q1 TTM) - -0.27 % 15.47 % 57.33 %
Sequential Net Income Change (Q1 TTM) - -3.32 % -6.74 % 18.65 %
Net Income 5 Year Avg. Growth - 4.12 % 9.21 % 22.96 %

AVNS's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) -21.43 % -15.76 % -25.81 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q1 MRQ) - 15.71 % -66.16 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) - - - -
Sequential EPS from Cont. Ops. Change (Q1 TTM) - - - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth - -1.8 % 0.17 % -28.52 %



AVNS EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) -21.43 % -18.03 % -26.29 % -28.52 %
Q / Q EPS Net Growth (Q1 MRQ) - 40.16 % -0.86 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q1 TTM) - - 0.15 % 4.93 %
EPS Net 5 Year Avg. Change - 4.12 % 9.21 % 22.96 %



Avanos Medical Inc 's sharp decrease of -21.43% in income per share in the first quarter from the same quarter a year ago, was much faster than income per share decline in the Medical Equipment & Supplies industry with -18.03%, but less than -26.29% slide in the Healthcare sector. Slow first quarter income per share inthe Healthcare sector and in the Medical Equipment & Supplies industry were portrayed in Avanos Medical Inc 's results, which underperformed overall market.

Comparing company's EPS to the fourth quarter results, income per share were higher by 0.72% . On the yearly basis, average annual income per share growth for Avanos Medical Inc is %, while S & P 500's including only the businesses with the first quarter 2026 Results, average annual income per share growth is 22.96% over the past five years.

AVNS Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) - 63.73 % 48.48 % 48.62 %
Sequential Free Cash Flow Change (Q1 MRQ) - -54.09 % -46.96 % 34.18 %
Y / Y Free Cash Flow Change (Q1 TTM) -93.42 % 39.68 % 18.61 % 60.27 %
Sequential Free Cash Flow Change (Q1 TTM) -82.6 % 8.02 % 5.39 % 15.75 %
Free Cash Flow 5 Year Avg. Change - 3.81 % 0.92 % 8.28 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) - - - 339.02 %
Sequential Net Cash Flow Change (Q1 MRQ) - - - 216.68 %
Y / Y Net Cash Flow Change (Q1 TTM) - - - 209.43 %
Sequential Net Cash Flow Change (Q1 TTM) - - - 152.64 %
Net Cash Flow 5 Year Avg. Change - -9.69 % 6.46 % 1.06 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) -35.82 % 4.81 % 8.23 % 120.03 %
Sequential Capital Expenditures Change (Q1 MRQ) -37.68 % -21.5 % -22.09 % 36.87 %
Y / Y Capital Expenditures Change (Q1 TTM) 43.14 % -1.63 % 7.86 % 109.38 %
Sequential Capital Expenditures Change (Q1 TTM) -7.59 % -1.55 % 1.6 % 23.05 %
Capital Expenditures 5 Year Avg. Change - 8.3 % 8.61 % 14.74 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.